Filing Details

Accession Number:
0001567619-22-007911
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-01 21:09:16
Reporting Period:
2022-03-31
Accepted Time:
2022-04-01 21:09:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1587221 Zosano Pharma Corp ZSAN Pharmaceutical Preparations (2834) 454488360
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1799864 Christine Matthews C/O Zosano Pharma Corporation
34790 Ardentech Court
Fremont CA 94555
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-03-31 8,116 $0.21 146,425 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to restricted stock units of the Issuer.